Feat: The Biosimilars Era; Challenges in pharma comms; This year's top clinical researchers
Biosimilars may have proven their worth, but how can adoption be sped up?
Pharma comms is one of the most dynamic sectors of the industry. So, what should be on communicators’ radar?
Can pharma prove that being patient centric is more than just a fad?
Celebrating 25 years of the Marketer of the Year competition
Teva is discontinuing a late-stage trial assessing the efficacy of its experimental anti-CGRP therapy fremanezumab in reducing cluster headaches.
18th June 2018
By 2023/24 there will be £20 billion more a year being spent on the NHS “in real terms”, Prime Minister Theresa May has revealed.
18th June 2018
UK-based digital therapy group Healios has raised £2.2 million in its latest funding round.
15th June 2018
Children and young people with X-linked hypophosphataemia (XLH) are unlikely to get routine access to Kyowa Kirin’s Crysvita on the NHS.
15th June 2018
US regulators have again expanded the list of approved uses of MSD’s immunotherapy Keytruda, issuing a green light for the treatment of primary mediastinal large B-cell lymphoma (PMBCL).
15th June 2018
The NIHR's Professor Chris Brightling explains how negative results from an asthma study can teach us just as much as positive results
Are current regulatory frameworks hindering therapy development for regenerative medicine?
The current state of the tissue engineering market
Graham Kershaw, Managing Director of packaging designers and manufacturers, Macpac, addresses consumer and some media concerns in regard to packaging waste – Guilty? Are We?
Dr Karishma Patel talks to PharmaTimes about the challenges of life with this ultra-rare genetic disorder
Pharma comms is one of the most dynamic sectors of the industry. So, what should be on communicators’ radar?
Biosimilars may have proven their worth, but how can adoption be sped up?
CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no existing drug treatment
We caught up with IQVIA’s SVP global technology solutions, Tal Rosenberg, at the 2018 eyeforpharma Barcelona conference as the company announced the EU launch of its Orchestrated Customer Engagement product, which aims to harmonise pharma's interaction with customers
Gene therapy still needs to overcome some major hurdles to truly fulfil its promise
Ana Nicholls asks whether GSK’s revenue drop is a short-term blip or a sign of bigger problems
Medical conferences provide one of the most valuable opportunities for pharma to engage with key stakeholders, but until recently, it was extremely difficult to gather and analyse relevant information from conference data
It seems as if the conversation around the nature of healthcare’s AI future is one that’s been conducted without the voices of patients themselves
Patient support programmes (PSPs) provide one of the biggest opportunities for pharma to put a patient-centric philosophy into practice
It all starts with listening to patients
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
Hikma has announced that Henriette Nielsen will take on the newly created role of chief transformation officer at the firm.
The Cell and Gene Therapy Catapult has appointed Dr Jonathan Appleby as chief scientific officer, with effect on October 1, 2018
Hanover Communications has named Sarah Matthew as the new chair of its Health practice.
